IV fosfomycin for serious bacterial infections
Part of Bones, joints & muscles, Brain & nervous system, Heart & circulation, Infections, Kidney & urinary, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This trial studies whether IV (through a vein) fosfomycin can treat severe bacterial infections in adults. It may help people whose infection is covered by the standard fosfomycin use and who need hospital-level care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your doctor needs to plan treatment with IV fosfomycin (through a vein) as the standard recommended use allows.
- Your infection must be one of the types listed, such as bone infection (osteomyelitis), complicated urine infection, hospital-acquired lung infection, bacterial meningitis/brain infections, bloodstream infection/sepsis, skin/soft tissue infection, or infection of the heart lining/valves (endocarditis).
- You (or your legally responsible representative) must be able to give written informed consent.
- You must not have an allergy to fosfomycin.
- You must not be in another interventional drug trial, and your situation must not be end-stage/comfort-only care (including “do not resuscitate” orders).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether fosfomycin works better than the usual treatment for children with urine infections caused by antibiotic-resistant germs. It may help by using an antibiotic choice that can still work when common oral options may fail.
This study looks at how well the antibiotic fosfomycin works for bacterial infections in patients who received it in the hospital. It may help doctors understand the best ways to use this medicine.
This trial tests an antibiotic called fosfomycin for treating urinary tract infections in men. It aims to see if it works well and safely in a primary care setting.
This trial tests BSG005, a new IV medicine for patients with invasive fungal infections that haven't improved with standard treatment or can't use standard treatments due to side effects or resistance. The goal is to see if it's safe and effective.
This trial tests if adding a bone-strengthening drug (bisphosphonate) to standard antibiotic treatment (vancomycin) works better for a certain type of long-term bone infection (osteomyelitis) that needs surgery. It may help people with a staph infection in their thigh or shin bone who are otherwise fairly healthy.
This trial tests a new drug, Fosmanogepix, for treating serious mold infections that are hard to treat with current medicines. It may be an option for people with limited treatment choices.
Hear when a new Bacterial Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.